EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Association Between Maternal Serum Ischemia-Modified Albumin Levels and Missed Abortion: A Case-Control Study

Didar Kurt, Pınar Yıldız

Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi · 29.04.2026 · 13 (1) · 80-85

DOI: 10.47572/muskutd.1827282 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, online erschienen am 29.04.2026. Verfasst von Didar Kurt und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early pregnancy loss is a multifactorial condition, and the biological pathways contributing to missed abortion are not fully understood. This study aimed to investigate maternal serum ischemia-modified albumin and albumin-adjusted ischemia-modified albumin concentrations in missed abortion and assess their potential relevance as markers of placental dysfunction. This prospective case–control study included pregnant women between 6 and 14 weeks of gestation. Women diagnosed with missed abortion formed the study group, and healthy pregnancies served as controls. Maternal serum ischemia-modified albumin and adjusted ischemia-modified albumin concentrations were measured. A total of 184 participants were enrolled, consisting of 74 cases and 110 controls. Serum ischemia-modified albumin concentrations were significantly higher in women with missed abortion (97.3 ng/mL [17.6–591.6] vs. 60.1 ng/mL [4–483], p=0.003), and the same trend was observed for albumin-adjusted ischemia-modified albumin (101.5 ng/mL [17.6–777.6] vs. 63.6 ng/mL [2.6–579.7], p=0.006). Receiver operating characteristic analysis yielded an area under the curve of 0.63 (95% CI: 0.55–0.70) for ischemia-modified albumin and 0.62 (95% CI: 0.54–0.70) for adjusted ischemia-modified albumin. The corresponding cut-off values were 63.5 ng/mL (sensitivity 75%, specificity 58%) and 75.8 ng/mL (sensitivity 66%, specificity 59%). These findings indicate that elevated ischemia-modified albumin levels may reflect oxidative imbalance and impaired placentation in missed abortion. While diagnostic performance was modest, the biomarker may still provide value when used alongside other clinical tools. Further prospective studies are needed to confirm these results and define its clinical applicability.

Zitieren

APA

Kurt, D., & Yıldız, P. (2026). Association Between Maternal Serum Ischemia-Modified Albumin Levels and Missed Abortion: A Case-Control Study. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 13(1), 80-85. https://doi.org/10.47572/muskutd.1827282

Vancouver

Kurt D, Yıldız P. Association Between Maternal Serum Ischemia-Modified Albumin Levels and Missed Abortion: A Case-Control Study. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi. 2026;13(1):80-85. doi:10.47572/muskutd.1827282

BibTeX
@article{Kurt2026,
  author = {Kurt, Didar and Yıldız, Pınar},
  title = {Association Between Maternal Serum Ischemia-Modified Albumin Levels and Missed Abortion: A Case-Control Study},
  journal = {Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {80--85},
  doi = {10.47572/muskutd.1827282}
}
Kostenlos starten →